>> Eurofins US News >> Eurofins Food Safety Systems Transfers ISO 17065 Accreditation to JAS-ANZ

Eurofins Food Safety Systems Transfers ISO 17065 Accreditation to JAS-ANZ

Sidebar Image

Eurofins Food Safety Systems Transfers ISO 17065 Accreditation to JAS-ANZ

Des Moines, IA, October 3, 2016

Eurofins Food Safety Systems announces the transition of its ISO 17065 accreditation for the scope of SQF V7.2 to the Joint Accreditation System of Australia and New Zealand, (JAS-ANZ). JAS-ANZ offers globally renowned accreditation services for businesses, regulators and government. JAS-ANZ accreditation is recognized and accepted around the world as the highest and most credible type of accreditation that a certification body can obtain.

"JAS-ANZ is pleased to congratulate Eurofins Food Safety Systems in gaining accreditation for ISO/IEC 17065:2012 and SQF,” said Kathryn Lockyer, General Manager of JAS-ANZ. “The assessment process confirms Eurofins’ internationally recognized capabilities in product certifications and food safety certifications. The recognition earned through these efforts maintains Eurofins’ credentials to service US and global market demands for food safety certification. We look forward to working with the Eurofins Food Safety Systems team.”

Eurofins Food Safety Systems is recognized for its efforts and capabilities in the field of food safety audits. As a certification body, Eurofins conducts audits to food safety standards benchmarked to GFSI (Global Food Safety Initiative). Additionally, Eurofins provides value-added assessments to manufacturers on a global basis. Successfully maintaining ISO 17065 accreditation through JAS-ANZ is another example of Eurofins’ competence and commitment to quality at the highest level.

“Being in the business of providing audits, we believe in the value of a deep-dive, independent look into our quality systems for improvement,” said Gary Smith, Director of Eurofins Food Safety Systems. “Partnering with a robust accreditation body such as JAS-ANZ has intrinsic value for us. This audit ensures we are doing the right thing for our customers and the industry.”
For more information, please visit

Notes for the editor:

Eurofins – a global leader in bio-analysis
Eurofins Scientific believes it is the world leader in food, environment and pharmaceutical products testing, as well as one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

With over 25,000 staff in more than 250 laboratories across 39 countries, Eurofins offers a portfolio of over 130,000 validated analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities and healthcare practitioners around the world.

The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Important disclaimer:

This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgment of Eurofins Scientific as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.